VAERS reports by lot
Sanofi Pasteur DTaP/Tdap lot C2826AA: VAERS reports
25 VAERS reports list lot C2826AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2007-09-20 and 2009-11-30. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).
Symptom categories in these reports
A report can mention several categories, so the counts add up to more than the number of reports.
| Category | Count | % |
|---|---|---|
| Injection-site / Local reaction | 29 | 29% |
| General / Systemic (non-local) | 24 | 24% |
| Musculoskeletal | 11 | 11% |
| Neurological | 9 | 9% |
| Allergic / Anaphylactic | 9 | 9% |
| Gastrointestinal | 8 | 8% |
| Dermatological (non-injection-site) | 5 | 5% |
| Cardiac / Cardiovascular | 4 | 4% |
| Respiratory | 1 | 1% |
Where reports came from
U.S. state of the reporter, where given (top 12).
| State | Reports |
|---|---|
| Virginia | 8 |
| Florida | 3 |
| California | 3 |
| Pennsylvania | 2 |
| Washington | 2 |
| Michigan | 1 |
| Utah | 1 |
| Oregon | 1 |
| Alaska | 1 |
| Missouri | 1 |
| Maryland | 1 |
| West Virginia | 1 |
Reports by month received
| Month | Reports | Bar |
|---|---|---|
| 2007-09 | 1 | |
| 2007-10 | 2 | |
| 2007-11 | 2 | |
| 2007-12 | 3 | |
| 2008-01 | 4 | |
| 2008-02 | 1 | |
| 2008-03 | 4 | |
| 2008-04 | 4 | |
| 2008-06 | 1 | |
| 2008-08 | 1 | |
| 2008-10 | 1 | |
| 2009-11 | 1 |
Products recorded with this lot
- Tdap — Sanofi Pasteur (25 reports)
Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.
Related
- All Sanofi Pasteur DTaP/Tdap lots with VAERS reports
- DTaP/Tdap vaccine lot number lookup
- DTaP/Tdap vaccine side effects, trials and ingredients
- Daptacel: ingredients, package insert and side effects
- Look up a lot for any vaccine
Nearby Sanofi Pasteur DTaP/Tdap lots (A–Z): C2774AA · C2775AA · C2825AA · C2842AA · C2844AA · C2862AA
Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.